MRA Advisory Group: F position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of MRA Advisory Group on F, newest first. How the timeline and the estimate are built.
MRA Advisory Group held 0 F shares at 2026-09-30 per its 13F-HR filed 2026-10-07.
the latest 13F is the newest step
- period ended2026-09-3013F 0 sharesChange vs previous 13F -12,861 shares
13F-HR 0001841816-26-000007 filed by MRA Advisory Group
Accepted , ingestedExited: the 13F for this period no longer lists the position.
- period ended2026-06-3013F 12,861 sharesChange vs previous 13F +12,861 shares
0.06% of the 13F portfolio, value $178,768.
13F-HR 0001841816-26-000003 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 0 sharesChange vs previous 13F -11,660 shares
13F-HR 0001841816-26-000001 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 11,660 sharesChange vs previous 13F -491 shares
0.06% of the 13F portfolio, value $139,453.
13F-HR 0001841816-25-000005 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 12,151 sharesChange vs previous 13F +12,151 shares
0.06% of the 13F portfolio, value $131,838.
13F-HR 0001841816-25-000003 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -12,714 shares
13F-HR 0001841816-25-000002 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 12,714 sharesChange vs previous 13F not available
0.07% of the 13F portfolio, value $125,869.
13F-HR 0001841816-25-000001 filed by MRA Advisory Group
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).